Overview
- 13 inspections across 13 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-04-26.
At a glance
Inspections
13
Sites
13
Observations
6
Career since
May 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Boehringer Ingelheim RCV GmbH & CO KG | 26 Apr 2013 | Human Drugs | On file |
| Merck SL | 26 Oct 2012 | On file | |
| FUJIFILM Diosynth Biotechnologies UK Ltd | 20 Jun 2012 | On file | |
| Kaneka Eurogentec SA | 27 Oct 2011 | On file | |
| SEAGEN INC. | 19 May 2011 | On file |
Sites inspected
Boehringer Ingelheim RCV GmbH & CO KGVienna, Austria1 insp.
Merck SLTres Cantos, Spain1 insp.
FUJIFILM Diosynth Biotechnologies UK LtdBillingham, United Kingdom1 insp.
Kaneka Eurogentec SAOugree, Belgium1 insp.
SEAGEN INC.Bothell, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Bo Chi7 shared
Steven Fong1 shared
Andrew J Idzior1 shared
Russell J Glapion1 shared
Anastasia G Lolas1 shared
Heika R Tait1 shared
Kalavati C Suvarna1 shared
Patricia F Hughes Troost1 shared
Full investigator report
Get the verbatim findings behind Mary E Farbman's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site